Is ARAV or STAG a better dividend investment in 2026?

ARAV currently yields 4987.53% with a 5% 5-year dividend growth rate. STAG yields 3.44% with 1% growth. The better choice depends on your goal: ARAV offers higher current income.

What is the dividend yield difference between ARAV and STAG?

ARAV has a forward dividend yield of 4987.53% ($2.00/share annually). STAG yields 3.44% ($1.24/share annually). The yield gap is 4984.09 percentage points.

Home › Compare › ARAV vs STAG

ARAV vs STAG: Dividend Comparison 2026

ARAV yields 4987.53% · STAG yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARAV wins by $60726414423802.57M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARAV

● Live price

4987.53%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$60726414423802.59M

Annual income

$58,422,163,401,288,310,000.00

Full ARAV calculator →

STAG

STAG Industrial Inc.

● Live price

3.44%

Share price

$36.09

Annual div

$1.24

5Y div CAGR

0.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$18.3K

Annual income

$462.22

Full STAG calculator →

Portfolio growth — ARAV vs STAG

📍 ARAV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARAV	STAG
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARAV + STAG cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARAV pays

STAG pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARAV

Annual income on $10K today (after 15% tax)

$423,940.15/yr

After 10yr DRIP, annual income (after tax)

$49,658,838,891,095,065,000.00/yr

STAG

Annual income on $10K today (after 15% tax)

$292.45/yr

After 10yr DRIP, annual income (after tax)

$392.89/yr

At 15% tax rate, ARAV beats the other by $49,658,838,891,095,065,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARAV + STAG for your $10,000?

ARAV: 50%STAG: 50%

100% STAG50/50100% ARAV

Portfolio after 10yr

$30363207211901.30M

Annual income

$29,211,081,700,644,155,000.00/yr

Blended yield

96.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARAV right now

ARAV

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$0.25

+523.4% upside vs current

Range: $0.25 — $0.25

Altman Z

-90.4

Piotroski

4/9

STAG

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$45.00

+24.7% upside vs current

Range: $39.00 — $59.00

Altman Z

1.2

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARAV buys

STAG buys

No recent congressional trades found for ARAV or STAG in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARAVSTAG

Forward yield	4987.53% ✓	3.44%
Annual dividend / share	$2.00 ✓	$1.24
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0.3% ✓
Portfolio after 10y	$60726414423802.59M ✓	$18.3K
Annual income after 10y	$58,422,163,401,288,310,000.00 ✓	$462.22
Total dividends collected	$60570499970588.68M ✓	$4.0K
Payment frequency	quarterly	monthly
Sector	Stock	REIT
Analyst consensus	Hold	Buy
Analyst price target	$0.25	$45.00 ✓

Year-by-year: ARAV vs STAG ($10,000, DRIP)

Year	ARAV Portfolio	ARAV Income/yr	STAG Portfolio	STAG Income/yr	Gap
1← crossover	$509,453	$498,753.12	$10,665	$345.09	+$498.8K → ARAV
2	$24,291,968	$23,746,853.30	$11,364	$357.70	+$24.28M → ARAV
3	$1,084,224,114	$1,058,231,708.37	$12,098	$370.43	+$1084.21M → ARAV
4	$45,302,256,588	$44,142,136,785.73	$12,869	$383.28	+$45302.24M → ARAV
5	$1,772,207,810,855	$1,723,734,396,305.83	$13,677	$396.23	+$1772207.80M → ARAV
6	$64,916,695,091,411	$63,020,432,733,796.11	$14,524	$409.27	+$64916695.08M → ARAV
7	$2,226,904,004,397,647	$2,157,443,140,649,837.00	$15,411	$422.41	+$2226904004.38M → ARAV
8	$71,550,063,790,460,920	$69,167,276,505,755,440.00	$16,339	$435.61	+$71550063790.44M → ARAV
9	$2,153,505,628,518,013,700	$2,076,947,060,262,220,500.00	$17,311	$448.89	+$2153505628518.00M → ARAV
10	$60,726,414,423,802,585,000	$58,422,163,401,288,310,000.00	$18,327	$462.22	+$60726414423802.57M → ARAV

ARAV vs STAG: Complete Analysis 2026

ARAV — Stock

Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong Kong) Limited to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.

Full ARAV Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →

📬

Get this ARAV vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARAV vs SCHD ARAV vs JEPI ARAV vs O ARAV vs KO ARAV vs MAIN ARAV vs PLD ARAV vs EQR ARAV vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.